دورية أكاديمية
A global action agenda for turning the tide on fatty liver disease
العنوان: | A global action agenda for turning the tide on fatty liver disease |
---|---|
المؤلفون: | Lazarus, Jeffrey V., Mark, Henry E., Allen, Alina M., Arab, Juan Pablo, Carrieri, Patrizia, Noureddin, Mazen, Alazawi, William, Alkhouri, Naim, Alqahtani, Saleh A., Anstee, Quentin M., Arrese, Marco, Bataller, Ramon, Berg, Thomas, Brennan, Paul N., Burra, Patrizia, Castro-Narro, Graciela E., Cortez-Pinto, Helena, Cusi, Kenneth, Dedes, Nikos, Duseja, Ajay, Francque, Sven M., Gastaldelli, Amalia, Hagström, Hannes, Huang, Terry T.K., Wajcman, Dana Ivancovsky, Kautz, Achim, Kopka, Christopher J., Krag, Aleksander, Newsome, Philip N., Rinella, Mary E., Romero, Diana, Sarin, Shiv Kumar, Silva, Marcelo, Spearman, C. Wendy, Terrault, Norah A., Tsochatzis, Emmanuel A., Valenti, Luca, Villota-Rivas, Marcela, Zelber-Sagi, Shira, Schattenberg, Jörn M., Wong, Vincent Wai Sun, Younossi, Zobair M., Aberg, Fredrik, Adams, Leon A., Al-Naamani, Khalid, Albadawy, Reda M., Alexa, Zinaida, Allison, Michael, Alnaser, Faisal Abdullatif, Macedo, Maria Paula |
المساهمون: | NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM), iNOVA4Health - pólo NMS |
سنة النشر: | 2023 |
المجموعة: | Repositório da Universidade Nova de Lisboa (UNL) |
مصطلحات موضوعية: | Hepatology, SDG 3 - Good Health and Well-being |
الوصف: | Funding Information: the Liver (CASL), Duke University, European Association for the Study of the Liver (EASL), Gastroenterology Updates, IBD, Liver Disease (GUILD), Houston Methodist, International Liver Transplantation Society (ILTS), Pakistan Society for the Study of Liver Disease (PSSLD), and University of Alabama, Birmingham (UAB). She received grants from Durect Corp, Genentech-Roche, Gilead, GlaxoSmithKline, Helio Health, and the National Institutes of Health. She has other interests with the American Association for the Study of Liver Diseases (AASLD), Clinical Care Options (CCO), the Hepatitis B Foundation, HBV Forum, Indian National Association for the Study of the Liver (INASL), and Simply Speaking. Emmanuel A. Tsochatzis consults, advises, and is on the speakers’ bureau for Novo Nordisk. He consults and advises Boehringer Ingelheim and Pfizer. He is on the speakers’ bureau for Dr Falk. He has other interests with EASL Governing Board. Luca Valenti consults, advises, is on the speakers’ bureau, and received grants from Gilead. He consults and advises Boehringer Ingelheim, Intercept, Pfizer, Novo Nordisk. He consults for Astra Zeneca and Diatech Pharmacogenetics. He is on the speakers’ board for AbbVie, Alfa-Sigma, MSD, and Viatris. He holds intellectual property rights with Takeda. Marcela Villota-Rivas consults for the European Association for the Study of The Liver (EASL). Shira Zelber-Sagi is on the speakers’ board for AbbVie. Jörn M. Schatten-berg consults, is on the speakers’ bureau, and is employed by Gilead. He consults, is on the speakers’ bureau, received grants from Boehringer Ingelheim. He consults and is on the speakers’ bureau for Madrigal and Novo Nordisk. He consults for Albireo Pharma, Apollo Endosurgery, Astra Zeneca, Bayer, Bristol Myers Squibb, GlaxoSmithKline, Intercept, Ipsen, Inventiva, MSD, Northsea Therapeutics, Novartis, Pfizer, Roche, Sanofi, and Siemens Healthineer. He is on the speakers’ bureau for Echosens, HistoIndex, and MedPublico GmbH. He received grants from, and ... |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
ردمك: | 978-85-16-91261-1 85-16-91261-2 |
تدمد: | 0270-9139 |
العلاقة: | PURE: 75211364; PURE UUID: 71c1fcb8-e7c7-4b2a-93a7-82f8a4603142; Scopus: 85169126126; PubMed: 37540183; ORCID: /0000-0002-2549-0275/work/151416335; http://hdl.handle.net/10362/159620Test; https://doi.org/10.1097/HEP.0000000000000545Test |
DOI: | 10.1097/HEP.0000000000000545 |
الإتاحة: | https://doi.org/10.1097/HEP.0000000000000545Test http://hdl.handle.net/10362/159620Test |
حقوق: | openAccess |
رقم الانضمام: | edsbas.D7818CFA |
قاعدة البيانات: | BASE |
ردمك: | 9788516912611 8516912612 |
---|---|
تدمد: | 02709139 |
DOI: | 10.1097/HEP.0000000000000545 |